Indonesia antirheumatic drugs market was valued at US$3,260.272 million in 2019. The market for antirheumatic drugs in Indonesia is projected to witness a healthy CAGR throughout the forecast period primarily on account of the high incidence of malaria throughout the country along with the moderate prevalence of numerous rheumatic diseases such as osteoarthritis and rheumatoid arthritis among others. According to the World Health Organization, the prevalence of osteoarthritis at the age Read more...
Iran antirheumatic drugs market was valued at US$1,519.779 million in 2019. The market for antirheumatic drugs in Iran is projected to grow account of the high prevalence of rheumatoid arthritis in the country along with the presence of a considerably high proportion of the geriatric population in the country. Furthermore, the rising incidence of cardiovascular diseases in the country is also anticipated to be one of the key factors supplementing the market growth in the country during t Read more...
Myanmar antirheumatic drugs market was valued at US$688.873 million in 2019. Significance prevalence of overweight and obesity in Myanmar is causing a rise in the number of people suffering from arthritis which, in turn, is driving the demand for antirheumatic drugs in the country. Growing ageing population in Myanmar, although at a slow pace, will also boost the market growth of antirheumatic drugs in the country to some extent during the forecast period. According to the latest census Read more...
Nigeria Antirheumatic Drugs market was valued at US$2,784.330 million in 2019. The primary factors that are driving the demand for numerous antirheumatic drugs in the country include the rising prevalence of malaria along with the constantly growing aging population of the country as the people with old age are more susceptible to various types of rheumatic diseases and chronic pains. According to the data provided by the World Bank Group, the geriatric population in the country has been Read more...
South Africa antirheumatic drugs market was valued at US$1,028.434 million in 2019. The market in South Africa is projected to grow at a notable CAGR throughout the forecast period. The major factors that drive the antirheumatic drugs market in the country include the high prevalence of rheumatoid arthritis coupled with the intense incidence of malaria throughout the country. According to the data from the World Health Organization, in 2018 the country reported around 9500 indigenous mal Read more...
Thailand antirheumatic drugs market was valued at US$915.846 million in 2019. The rising rate of disease prevalence including osteoarthritis and rheumatoid arthritis in Thailand is the major driver of antirheumatic drugs market in the country. Unhealthy lifestyle has resulted in an increases burden of various chronic diseases such as obesity and diabetes in Thailand which can cause arthritis, gout, and lupus as well. According to the country’s Ministry of Public Health, more than 3 Read more...
Turkey antirheumatic drugs market was valued at US$1,493.931 million in 2019. The major factor driving the antirheumatic drugs market growth in Turkey includes the rising risk of the reintroduction of localized outbreaks of malaria throughout the country. However, there has been a dramatic decrease in the number of malaria cases and their active foci. Furthermore, the high prevalence of non-communicable disease in the country such as heart diseases, cancer, diabetes, osteoarthritis, and Read more...
Vietnam antirheumatic drugs market was valued at US$1,205.182 million in 2019. Increasing incidence of malaria is driving the demand for antirheumatic drugs in the country. Mushrooming number of people suffering from arthritis in Vietnam is another major factor that is spurring the demand for antirheumatic drugs in the country. In 2019, the University of Medical Center in Ho Chi Minh City reported the ever-increasing number of rheumatoid arthritis patients. With growing adoption of Weste Read more...
Bangladesh antirheumatic drugs market was valued at US$1,953.071 million in 2019. Increasing cases of rheumatoid arthritis in Bangladesh is one of the major factors that is fuelling the market growth of antirheumatic drugs in the country. Another major driver is the prevalence of malaria in Bangladesh which is a significant public health problem in the country. Increasing burden of chronic diseases coupled with growing geriatric population is further boosting the demand for antirheumatic Read more...
Asia Pacific (APAC) Antirheumatic Drugs market was valued at US$44,513.265 million in 2019. The rapidly growing number of patients suffering from various lifestyle-related diseases is one of the major factors behind the growth of the antirheumatic drug market in the region. There has been a continuous rise in the prevalence of diabetes in countries like China, India, and South Korea. In India, for example, according to the World Bank Group, the prevalence of diabetes among individuals ag Read more...
.jpg)
